For decades, scientists believed molecules called leukotrienes were the main culprits behind asthma’s airway-constricting ...

A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...

Researchers have developed a new method to treat severe asthma. In a study of over 200 participants with severe asthma, the new treatment was shown to have improved asthma symptoms and lung function, ...

An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a ...

Asthma is one of the most common chronic immunological diseases in humans, affecting people from childhood to old age. Progress in treating asthma has been relatively slow and treatment guidelines ...

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple ...

New research presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI ...

The study found that a peanut patch treatment—called epicutaneous immunotherapy, or EPIT—continued to help toddlers safely ...